InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
64,129.57
(
-0.06%
)
Post# of 1954
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

inthequeue50

Send PM Follow Ignore
Followers 72
Posts 2022
Boards Moderated 0
Alias Born 03/11/2014

inthequeue50

Re: None

Thursday, 12/11/2014 8:58:26 AM

Thursday, December 11, 2014 8:58:26 AM

Post# of 1954
EBOLA VACCINE TRIAL HALTED....

http://www.trust.org/item/20141211135112-u358o

GENEVA, Dec 11 (Reuters) - A clinical trial of an Ebola vaccine developed by Merck and NewLink has been halted temporarily as a precautionary measure after four patients complained of joint pains, the University of Geneva Hospital said on Thursday.

"They are all fine and being monitored regularly by the medical team leading the study," it said in a statement.

The human safety trials, which began in Geneva on Nov. 10, are due to resume on Jan. 5 in up to 15 volunteers after checks to ensure that joint pain symptoms in hands and feet were "benign and temporary", the hospital said. Fifty nine volunteers have been vaccinated so far.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up